No Data
No Data
Express News | Aligos Therapeutics Inc - Topline Data Now Projected in Early Q4 2024
Express News | Aligos Therapeutics Announces the Completion of Enrollment in the Alg-055009 Phase 2a Herald Study for the Treatment of Mash
Piper Sandler Keeps Their Buy Rating on Aligos Therapeutics (ALGS)
Aligos Therapeutics Announces Chief Medical Officer Resignation
Why Investors Shouldn't Be Surprised By Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) 26% Share Price Plunge
The Aligos Therapeutics, Inc. (NASDAQ:ALGS) share price has softened a substantial 26% over the previous 30 days, handing back much of the gains the stock has made lately. The drop over the last 30
Aligos Therapeutics Reports Q1 Results
No Data